Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 4/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TET3 | O43151 | 1/20 | 0.31 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.31 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.30 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14244998 | 0.93 | ACE2 (0.35) | TET2BLMTBXAS1ACE2 | |
| SCHEMBL2593852 | 0.89 | TET2 (0.38) | TET2TET3TET1 | |
| SCHEMBL585178 | 0.81 | MAPT (0.41) | MAPT | |
| SCHEMBL8141493 | 0.79 | TET2 (0.42) | TET2BLMTET3TET1TBXAS1 | |
| SCHEMBL4929618 | 0.79 | ACE2 (0.36) | TET2BLMMAPTTET3TET1 | |
| SCHEMBL150693 | 0.79 | TET2 (0.34) | TET2BLMMAPTACE2 | |
| SCHEMBL7631881 | 0.78 | ACE2 (0.43) | TET2BLMMAPTTET3TET1 | |
| SCHEMBL11614360 | 0.78 | BLM (0.55) | BLMACE2 | |
| SCHEMBL16318792 | 0.78 | ACE2 (0.47) | BLMMAPTACE2 | |
| SCHEMBL11614364 | 0.78 | BLM (0.55) | BLMACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2504288-B1 | OPTICAL FIBER WITH DOUBLE COATING | PRYSMIAN SPA (IT) | 2019-04-17 | — | — | EP | claimed |
| US-8781282-B2 | Optical fiber with double coating | PRYSMIAN S.P.A. (IT) | 2014-07-15 | — | — | US | claimed |
| US-20120321265-A1 | OPTICAL FIBER WITH DOUBLE COATING | PRYSMIAN S.P.A. (IT) | 2012-12-20 | — | — | US | claimed |
| EP-1793877-B1 | MEDICATED COATINGS FOR IMPLANTABLE MEDICAL DEVICES INCLUDING POLYACRYLATES | ABBOTT CARDIOVASCULAR SYSTEMS (US) | 2009-09-02 | — | — | EP | claimed |
| EP-3642284-B1 | CURABLE ORGANOPOLYSILOXANE COMPOSITIONS | WACKER CHEMIE AG (DE) | 2022-06-01 | — | — | EP | disclosed |
| US-20210403619-A1 | High-Molecular-Weight Compound and Method for Producing Same, Composition and Method for Producing Same, Resin Composition, Additive for Lubricating Oil, and Lubricating Oil | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-12-30 | — | — | US | disclosed |
| US-9822207-B2 | Silicon-containing highly branched polymer and curable composition containing the same | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-11-21 | — | — | US | disclosed |
| EP-1654296-B1 | PHOSPHONIC ACID-MODIFIED MICROGEL DISPERSION | BOLLIG & KEMPER GMBH & CO KG (DE) | 2016-02-17 | — | — | EP | disclosed |
| US-20150299500-A1 | CURABLE COMPOSITION CONTAINING SILICON-CONTAINING HIGHLY-BRANCHED POLYMER | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-10-22 | — | — | US | disclosed |
| US-20150210797-A1 | SILICON-CONTAINING HIGHLY BRANCHED POLYMER AND CURABLE COMPOSITION CONTAINING THE SAME | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-07-30 | — | — | US | disclosed |
| EP-1554323-B1 | PHOSPHONIC ACID-MODIFIED MICROGEL DISPERSION | BOLLIG & KEMPER GMBH & CO KG (DE) | 2015-04-22 | — | — | EP | disclosed |
| US-8781282-B2 | Optical fiber with double coating | PRYSMIAN S.P.A. (IT) | 2014-07-15 | — | — | US | disclosed |
| WO-1988002010-A1 | BRANCHED POLYMERISATE CONTAINING SILYL GROUPS, PROCESS FOR ITS MANUFACTURE, COATING AGENTS BASED ON THIS POLYMERISATE AS WELL AS THEIR USE | BASF LACKE + FARBEN AKTIENGESELLSCHAFT (DE) | 1988-03-24 | — | — | WO | disclosed |
| EP-0254722-A1 | HARDENABLE COMPOSITION. | BASF LACKE & FARBEN (DE) | 1988-02-03 | — | — | EP | disclosed |
| EP-0242513-A1 | Coating on the basis of an acrylate copolymer having hydroxy, carboxylic and tertiary amino-groups, process for the preparation of the coating and its use | BASF Lacke + Farben AG (DE) | 1987-10-28 | — | — | EP | disclosed |
| WO-1987002041-A1 | SOLUBLE ACRYLIC COPOLYMER CONTAINING CARBOXYL GROUPS, ITS PRODUCTION PROCESS AND COATING AGENT ON THE BASIS OF THIS ACRYLIC COPOLYMER | BASF LACKE + FARBEN AKTIENGESELLSCHAFT (DE) | 1987-04-09 | — | — | WO | disclosed |
| WO-1987002044-A1 | HARDENABLE COMPOSITION | BASF LACKE + FARBEN AKTIENGESELLSCHAFT (DE) | 1987-04-09 | — | — | WO | disclosed |
| WO-1985004665-A1 | ACRYLIC COPOLYMER CONTAINING HYDROXYL GROUPS, PROCESS FOR THE PREPARATION THEREOF AND COATING BASED ON SAID ACRYLIC COPOLYMER | BASF FARBEN + FASERN AKTIENGESELLSCHAFT (DE) | 1985-10-24 | — | — | WO | disclosed |
| EP-0158161-A1 | Acrylate copolymers containing hydroxyl groups, process for their preparation and coating compositions based on these acrylate copolymers | BASF Lacke + Farben AG (DE) | 1985-10-16 | — | — | EP | disclosed |
| EP-0154819-A1 | Method of adhesion and composition therefor | Takeda Chemical Industries, Ltd. (JP) | 1985-09-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210403619-A1 | High-Molecular-Weight Compound and Method for Producing Same, Composition and Method for Producing Same, Resin Composition, Additive for Lubricating Oil, and Lubricating Oil | TMT1A, TST, NOTUM | TET2 2415/4885BLM 2912/4885MAPT 1324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.